Literature DB >> 15623687

Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria.

M K Bruno1, M Hallett, K Gwinn-Hardy, B Sorensen, E Considine, S Tucker, D R Lynch, K D Mathews, K J Swoboda, J Harris, B W Soong, T Ashizawa, J Jankovic, D Renner, Y H Fu, L J Ptacek.   

Abstract

BACKGROUND: Paroxysmal kinesigenic dyskinesia (PKD) is a rare disorder characterized by short episodes of involuntary movement attacks triggered by sudden voluntary movements. Although a genetic basis is suspected in idiopathic cases, the gene has not been discovered. Establishing strict diagnostic criteria will help genetic studies.
METHODS: The authors reviewed the clinical features of 121 affected individuals, who were referred for genetic study with a presumptive diagnosis of idiopathic PKD.
RESULTS: The majority (79%) of affected subjects had a distinctive homogeneous phenotype. The authors propose the following diagnostic criteria for idiopathic PKD based on this phenotype: identified trigger for the attacks (sudden movements), short duration of attacks (<1 minute), lack of loss of consciousness or pain during attacks, antiepileptic drug responsiveness, exclusion of other organic diseases, and age at onset between 1 and 20 years if there is no family history (age at onset may be applied less stringently in those with family history). In comparing familial and sporadic cases, sporadic cases were more frequently male, and infantile convulsions were more common in the familial kindreds. Females had a higher remission rate than males. An infantile-onset group with a different set of characteristics was identified. A clear kinesigenic trigger was not elicited in all cases, antiepileptic response was not universal, and some infants had attacks while asleep.
CONCLUSIONS: The diagnosis of idiopathic paroxysmal kinesigenic dyskinesia (PKD) can be made based on historical features. The correct diagnosis has implications for treatment and prognosis, and the diagnostic scheme may allow better focus in the search for the PKD gene(s).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623687     DOI: 10.1212/01.wnl.0000147298.05983.50

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  95 in total

1.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Mild paroxysmal kinesigenic dyskinesia caused by PRRT2 missense mutation with reduced penetrance.

Authors:  Jennifer Friedman; Jesus Olvera; Jennifer L Silhavy; Stacey B Gabriel; Joseph G Gleeson
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

3.  Analysis of catechol-O-methyltransferase gene mutation and identification of new pathogenic gene for paroxysmal kinesigenic dyskinesia.

Authors:  Chengzhi Gu; Jia Li; Lianhai Zhu; Zhenhui Lu; Huaiyu Huang
Journal:  Neurol Sci       Date:  2015-12-09       Impact factor: 3.307

4.  Paroxysmal Kinesigenic Dyskinesia May Be Misdiagnosed in Co-occurring Gilles de la Tourette Syndrome.

Authors:  Christos Ganos; Niccolo Mencacci; Alice Gardiner; Roberto Erro; Amit Batla; Henry Houlden; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

5.  A case of concurrent diurnal and nocturnal paroxysmal dystonia.

Authors:  Shenghua Li; Xiaomin Pang; Lan Chen; Chunyong Chen; Jingli Liu
Journal:  Neurol Sci       Date:  2018-08-13       Impact factor: 3.307

6.  A Novel Truncation Mutation of the PRRT2 Gene Resulting in a 16-Amino-Acid Protein Causes Self-inducible Paroxysmal Kinesigenic Dyskinesia.

Authors:  Makoto Kita; Yasuhiro Kuwata; Nagako Murase; Yuichi Akiyama; Takeshi Usui
Journal:  Mov Disord Clin Pract       Date:  2017-05-23

7.  Altered intrinsic brain activity in patients with paroxysmal kinesigenic dyskinesia by PRRT2 mutation: altered brain activity by PRRT2 mutation.

Authors:  ChunYan Luo; Yongping Chen; Wei Song; Qin Chen; QiYong Gong; Hui-Fang Shang
Journal:  Neurol Sci       Date:  2013-03-27       Impact factor: 3.307

8.  Clinical manifestations in paroxysmal kinesigenic dyskinesia patients with proline-rich transmembrane protein 2 gene mutation.

Authors:  Jinyoung Youn; Ji Sun Kim; Munhyang Lee; Jeehun Lee; Hakjae Roh; Chang-Seok Ki; Jin Whan Choa
Journal:  J Clin Neurol       Date:  2014-01-06       Impact factor: 3.077

9.  PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine.

Authors:  Robin Cloarec; Nadine Bruneau; Gabrielle Rudolf; Annick Massacrier; Manal Salmi; Marc Bataillard; Clotilde Boulay; Roberto Caraballo; Natalio Fejerman; Pierre Genton; Edouard Hirsch; Alasdair Hunter; Gaetan Lesca; Jacques Motte; Agathe Roubertie; Damien Sanlaville; Sau-Wei Wong; Ying-Hui Fu; Jacques Rochette; Louis J Ptácek; Pierre Szepetowski
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

10.  PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures.

Authors:  Ingrid E Scheffer; Bronwyn E Grinton; Sarah E Heron; Sara Kivity; Zaid Afawi; Xenia Iona; Hadassa Goldberg-Stern; Maria Kinali; Ian Andrews; Renzo Guerrini; Carla Marini; Lynette G Sadleir; Samuel F Berkovic; Leanne M Dibbens
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.